Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PROCEPT BioRobotics (PRCT) Equity Average (2020 - 2026)

PROCEPT BioRobotics has reported Equity Average over the past 7 years, most recently at $356.8 million for Q1 2026.

  • Quarterly Equity Average fell 9.84% to $356.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $356.8 million through Mar 2026, down 9.84% year-over-year, with the annual reading at $384.0 million for FY2025, 12.46% up from the prior year.
  • Equity Average was $356.8 million for Q1 2026 at PROCEPT BioRobotics, down from $373.1 million in the prior quarter.
  • Over five years, Equity Average peaked at $395.7 million in Q1 2025 and troughed at $164.5 million in Q2 2023.
  • The 5-year median for Equity Average is $259.9 million (2022), against an average of $282.7 million.
  • Year-over-year, Equity Average soared 497.29% in 2022 and then plummeted 33.12% in 2023.
  • A 5-year view of Equity Average shows it stood at $208.9 million in 2022, then surged by 38.84% to $290.1 million in 2023, then rose by 10.92% to $321.7 million in 2024, then grew by 15.96% to $373.1 million in 2025, then decreased by 4.37% to $356.8 million in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Equity Average are $356.8 million (Q1 2026), $373.1 million (Q4 2025), and $383.0 million (Q3 2025).